Meta-analysis of the effects of beta blocker on survival time in cancer patients (Q35132413)

6 August 2017

0 references

Meta-analysis of the effects of beta blocker on survival time in cancer patients (English)

1 reference

6 August 2017

1 reference

Byoung-Gie Kim

1 reference

6 August 2017

Chel Hun Choi

1 reference

6 August 2017

Taejong Song

1 reference

6 August 2017

Tae Hyun Kim

1 reference

6 August 2017

Jun Kuk Choi

1 reference

6 August 2017

Jin-Young Park

1 reference

6 August 2017

Aera Yoon

1 reference

6 August 2017

Yoo-Young Lee

1 reference

6 August 2017

Tae-Joong Kim

1 reference

6 August 2017

Duk-Soo Bae

1 reference

6 August 2017

Jeong-Won Lee

1 reference

6 August 2017

publication date

27 March 2014

1 reference

Journal of Cancer Research and Clinical Oncology

6 August 2017

published in

1 reference

6 August 2017

volume

140

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

1179-1188

1 reference

Stimulation of tumour growth by wound-derived growth factors

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Impact of beta blockers on epithelial ovarian cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Incidence of and mortality from cancer in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Surgical stress promotes tumor growth in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Protective and Damaging Effects of Stress Mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Stress, depression, the immune system, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Stress hormone-mediated invasion of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Functional beta-adrenergic receptors in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1658-7

Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor

21 January 2018

1 reference

12 December 2020

Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival

1 reference

12 December 2020

Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma

1 reference

12 December 2020

Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection

1 reference

12 December 2020

Antimetastatic activity of a cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers

1 reference

12 December 2020

Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease

1 reference

12 December 2020

10.1007/S00432-014-1658-7

Identifiers

DOI

1 reference

release_lhkei5zukzfhxdibtgtgfbmhni

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lhkei5zukzfhxdibtgtgfbmhni

24 November 2022

mapped directly with Wikidata item

1 reference